
    
      This treatment protocol will serve as a mechanism to continue to provide ficlatuzumab to
      patient 0001-000412, who was previously enrolled under protocol P05538 and whom the
      investigator believes is deriving clinical benefit from ficlatuzumab treatment.
    
  